Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Sign In to gain access to subscriptions and/or personal tools.
Perfusion
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Touchot, B.
Right arrow Articles by Piwnica, A.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Touchot, B.
Right arrow Articles by Piwnica, A.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Use of low molecular weight heparin CY 222 during cardiopulmonary bypass. Experimental study and clinical application

B. Touchot

Service de Chururgie Cardiaque, Hopital Lariboisière, 2 rue Ambroise Paré, 75475 Paris Cedex 10, France

F. Laborde

Service de Chururgie Cardiaque, Hopital Lariboisière, 2 rue Ambroise Paré, 75475 Paris Cedex 10, France

F. Dum

Service de Chururgie Cardiaque, Hopital Lariboisière, 2 rue Ambroise Paré, 75475 Paris Cedex 10, France

P. Commin

Service de Chururgie Cardiaque, Hopital Lariboisière, 2 rue Ambroise Paré, 75475 Paris Cedex 10, France

P. Gallix

Service de Chururgie Cardiaque, Hopital Lariboisière, 2 rue Ambroise Paré, 75475 Paris Cedex 10, France

M. Mirshahi

Service de Chururgie Cardiaque, Hopital Lariboisière, 2 rue Ambroise Paré, 75475 Paris Cedex 10, France

A. Piwnica

Service de Chururgie Cardiaque, Hopital Lariboisière, 2 rue Ambroise Paré, 75475 Paris Cedex 10, France

Cardiopulmonary bypass (CPB) standard heparin and protamine therapy is a relatively satisfactory part of conventional CPB practice. However, some problems are known to result from both heparin and protamine sulphate administration. These include: allergic reaction and thrombocytopenia due to heparin, and anaphylactoid reactions, negative inotropic effects, pulmonary oedema and pulmonary hypertension due to protamine administration.

Low molecular weight heparin (LMWH) should theoretically be superior decreasing the adverse effects of standard heparin. In addition, it should not require the use of protamine for heparin neutralization.

These potential benefits of LMWH encourage the experimental evaluation of the use of LMWH during open-heart surgery before preliminary clinical applications.

Perfusion, Vol. 1, No. 2, 99-102 (1986)
DOI: 10.1177/026765918600100204
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?